SEC Tracker
Get the app

Pulmatrix PULM

Pulmatrix FY 2025: net loss $5.2M; diluted EPS −$1.41

Form
10-K/A
Filed
Period
Importance
Routine

Key figures from this report

These are the numbers Pulmatrix reported for the year ended Dec 31, 2025, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Net income−$5.2MAgainst −$9.6M in FY 202410-K/A income statement, on EDGAR
  2. Diluted EPS−$1.41Against −$2.62 in FY 202410-K/A income statement, on EDGAR
  3. Cash and cash equivalents$4.1M−57% from $9.5M in FY 202410-K/A balance sheet, on EDGAR
  4. Cash from operations−$5.4MAgainst −$10.7M in FY 202410-K/A cash flow statement, on EDGAR

Every year in the financial tables

View on EDGAR

Open in the app

Get an email when Pulmatrix files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.